| III-68 Sarah Lezzar Population pharmacokinetics and pharmacodynamics analysis of hydroxyurea, in adult patients with sickle cell anemia (SCA), and evaluation of disease markers Thursday 09:50-11:20 |
| III-68 Sarah Lezzar Population pharmacokinetics and pharmacodynamics analysis of hydroxyurea, in adult patients with sickle cell anemia (SCA), and evaluation of disease markers Thursday 09:50-11:20 |